Skip to content
Home/Companies/Biotech/Atelerix
Atelerix

Atelerix

Biotech·UK·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Atelerix?

Atelerix is currently owned by Future Planet Capital through UK Innovation and Science Seed Fund (2012 vintage), since 2018. Across its history, Atelerix has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Future Planet Capital
Most recent investor
Future Planet Capital
UK Innovation and Science Seed Fund · 2012 · VC
2 ownership periods · full history below

Key facts

HQUK
SectorBiotech
Websitewww.atelerix.co.uk

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Future Planet Capital and ACF Investors since 2018.
Co-invest · 2 holders · 2018 · present
Future Planet Capital
Future Planet CapitalActive
2018 · present(8yr) · UK Innovation and Science Seed Fund · 2012 · VC
ACF Investors
ACF InvestorsActive
2025 · present(1yr) · Angel CoFund · 2011 · VC

More from UK Innovation and Science Seed Fund

Other portfolio companies in the same fund.

52North Health
52North Health
Active
HealthTechUK
Akrivia Health
Akrivia Health
Active
HealthTechUK
Antiverse
Antiverse
Active
BiotechUK
CellCentric
CellCentric
Active
BiotechUK
Clare Sys
Clare Sys
Active
Deep TechUK
Crescendo Biologics
Crescendo Biologics
Active
BiotechUK

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue